Skip to Content

GSI 704 (Truvada 133 mg / 200 mg)

Generic Name: emtricitabine/tenofovir

Pill with imprint GSI 704 is Blue, Rectangle and has been identified as Truvada 133 mg / 200 mg. It is supplied by Gilead Sciences, Inc..

Truvada is used in the treatment of pre-exposure prophylaxis; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 133 mg / 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for GSI 704

Truvada

Generic Name:
emtricitabine/tenofovir
Imprint:
GSI 704
Strength:
133 mg / 200 mg
Color:
Blue
Shape:
Rectangle
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Gilead Sciences, Inc.
National Drug Code (NDC):
61958-0704

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide